Mr. Beat Up
speaker
680 appearances
3 recordings
1 series
first heard Jun 2026
last heard 8 Jul
Mr. Beat Up’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 3 in all, peaking in Jun 2026 with 2.
Appearances
So a number of those big pharmaceutical names do sit at the top of those indexes.
But if we go over to America, there are more pure play pharmaceutical and biotech ETFs.
Now, if you want to go even more speculative, Cathie Wood has an ETF for you.
The Arc Genomic Revolution ETF was really focused.
Well, it still is focused on a lot of those longevity themes and gene editing.
It hasn't done well as an ETF, we should say.
Then there's quite a cancer-focused one.
There's an oncology ETF.
The ticker is C-A-N-C, and it is only on cancer-focused biotechs.
Yeah.
The US has more ETFs than they do individual stocks at this point.
So there's obviously more range there.
My concluding thought is because of how difficult it is to commercialize drugs, because like once you get through the clinical trials, you then have to build distribution and you have to sell it, particularly in America, you have to sell it into the hospitals and everything.
There's a real power law.
It's like the big get bigger.
And so when you're thinking about investing in it,
It's similar to mining again.
You can really take a bet on some of these smaller players.
If you just want exposure to the overall thematic growing, you don't have to go too far down the index.
Absolutely.
Showing 201–220 of 680 · page 11 of 34
← Previous
Next →